Carl Zeiss Meditec AG

  • WKN: 531370
  • ISIN: DE0005313704
  • Land: Deutschland

Nachricht vom 19.04.2022 | 16:00

Carl Zeiss Meditec acquires two manufacturers of surgical instruments

DGAP-News: Carl Zeiss Meditec AG / Key word(s): Takeover
Carl Zeiss Meditec acquires two manufacturers of surgical instruments
19.04.2022 / 16:00
The issuer is solely responsible for the content of this announcement.

Carl Zeiss Meditec acquires two manufacturers of surgical instruments
 
Carl Zeiss Meditec announced today the acquisition of two manufacturers of surgical instruments (Kogent Surgical, LLC and Katalyst Surgical, LLC) to further strengthen its positioning as a solution provider
 

Jena/Germany | 19 April 2022

Kogent Surgical and Katalyst Surgical are based in Chesterfield, Missouri (USA) and were founded by entrepreneur Gregg Scheller. Carl Zeiss Meditec AG President and CEO Dr. Markus Weber states: "This is a strategically important acquisition for ZEISS Medical Technology. We expect this acquisition to scale the businesses and contribute to our surgical solution offering and add recurring revenue." Gregg Scheller comments: "We already have a successful, long-term partnership with ZEISS and FCI (France Chirurgie Instrumentation S.A.S.) and we look forward to jointly expanding our solutions into other ZEISS applications and customer specialties." Financial terms of the deal are not disclosed.

Contact for investors and the press
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220 116
Mail: investors.meditec@zeiss.com


www.zeiss.com/newsroom
 



19.04.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

Landi Renzo: GBC-Interview mit CEO Christiano Musi

„Der Lani Renzo-Konzern ist ein globaler Akteur, der sich auf die Energiewende entlang der gesamten Wertschöpfungskette spezialisiert hat und darauf abzielt, ein weltweiter Referenzpunkt für RNG- und Wasserstoffanwendungen bei Green Mobility und Clean-Tech-Lösungen zu werden. Bis 2025 erwarten wir Umsatzzuwächse von 15% (CAGR) und ein zweistelliges EBITDA-Wachstum von 25% (CAGR), dank ansteigender Umsätze in Segmenten, die im Vergleich zu unserem traditionellen Markt für leichte Nutzfahrzeuge höhere Margen aufweisen."

Events im Fokus

Termine 2022

12./13. Oktober 2022: Fachkonferenz Finanzdienstleistungen/Technologie

News im Fokus

Henkel AG & Co. KGaA: Henkel steigert Umsatz deutlich, treibt strategische Agenda voran und hebt Umsatzprognose für 2022 an

15. August 2022, 07:30

Aktueller Webcast

Nordex SE

Conference Call 15.08.2022 (Webcast)

15. August 2022

Aktuelle Research-Studie

Energiekontor AG

Original-Research: Energiekontor AG (von First Berlin Equity Research GmbH): Hinzufügen

15. August 2022